
VXRT
Healthcare · Biotechnology · $90.2M market cap
$0.3620-0.02 (-4.5%)Nov 13, 3:58 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 12, 2026 | After the close | -0.21 | -0.06 | +71.4% |
| May 7, 2026 | After the close | 0.02 | 0.02 | 0.0% |
| Mar 19, 2026 | Time not confirmed | -0.06 | 0.24 | +500.0% |
| Nov 13, 2025 | After the close | -0.06 | -0.04 | +33.3% |
| Aug 13, 2025 | After the close | -0.09 | -0.07 | +22.2% |
| May 13, 2025 | After the close | -0.07 | -0.07 | 0.0% |
| Mar 12, 2025 | Before the open | -0.11 | -0.05 | +54.5% |
| Nov 13, 2024 | After the close | -0.08 | -0.06 | +25.0% |
| Aug 8, 2024 | After the close | 0.04 | -0.09 | -325.0% |
| May 13, 2024 | After the close | -0.18 | -0.14 | +22.2% |
| Mar 14, 2024 | After the close | -0.14 | -0.12 | +14.3% |
| Nov 2, 2023 | After the close | -0.18 | -0.11 | +38.9% |
| Aug 3, 2023 | After the close | -0.17 | -0.16 |
Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII; COVID-19 Vaccine, which is in Phase 2b clinical trial for the treatment…
| +5.9% |
| May 4, 2023 | After the close | -0.16 | -0.19 | -18.8% |
| Mar 15, 2023 | After the close | -0.23 | -0.18 | +21.7% |
| Nov 8, 2022 | After the close | -0.25 | -0.23 | +8.0% |
| Aug 8, 2022 | After the close | -0.21 | -0.23 | -9.5% |
| May 9, 2022 | After the close | -0.16 | -0.20 | -25.0% |
| Feb 24, 2022 | After the close | -0.16 | -0.17 | -6.3% |
| Nov 4, 2021 | After the close | -0.14 | -0.14 | 0.0% |
| Aug 5, 2021 | After the close | -0.14 | -0.13 | +7.1% |
| May 3, 2021 | Before the open | -0.10 | -0.14 | -40.0% |
| Feb 25, 2021 | After the close | -0.05 | -0.13 | -160.0% |
| Nov 12, 2020 | After the close | -0.09 | -0.08 | +11.1% |
| Aug 6, 2020 | After the close | -0.05 | -0.12 | -140.0% |
| May 12, 2020 | After the close | -0.04 | -0.02 | +50.0% |
| Mar 19, 2020 | After the close | -0.13 | -0.13 | 0.0% |
| Nov 12, 2019 | After the close | -0.35 | -0.32 | +8.6% |
| Aug 8, 2019 | After the close | -0.50 | -0.39 | +22.0% |
| May 9, 2019 | After the close | — | -0.18 | — |
| Feb 6, 2019 | After the close | -2.86 | -0.69 | +75.9% |
| Nov 9, 2018 | After the close | -1.76 | -0.92 | +47.7% |
| Aug 9, 2018 | Before the open | -2.86 | -1.24 | +56.6% |
| May 15, 2018 | After the close | -2.90 | 0.49 | +116.9% |